BOCIMED
BociMed is a company engaged in drug research and development and clinical research. Through the establishment of a standardized service system, it provides high-quality R&D and outsourcing services for drug discovery, preclinical pharmaceutical research and development, clinical I-IV trials and registration.Shanghai Bozhiyan New Drug Technology Co., Ltd. is a high-tech enterprise specializing in drug research and development technical services, Shanghai High-tech Enterprise, Shanghai Credit Cre... ation Enterprise, and Shanghai Small and Medium Enterprise Innovation Undertaking Enterprise. The company started in 2007 and was formerly known as Shanghai Maibo Pharmaceutical Technology Co., Ltd., registered in Jinshan Petrochemical Zone, mainly engaged in raw material sales, drug import registration and regional cooperation development in China. In 2012,
BOCIMED
Industry:
Biotechnology Clinical Trials Health Care Information Technology
Founded:
2012-01-01
Address:
Shanghai, Shanghai, China
Country:
China
Website Url:
http://www.abc.bocimed.com
Total Employee:
101+
Status:
Active
Contact:
68861631, 68861632
Email Addresses:
[email protected]
Total Funding:
0
Technology used in webpage:
Viewport Meta Nginx IIS IIS 7 China Telecom Tencent Cloud Tencent Waterproof Wall
Investors List
Shanghai STVC Group
Shanghai STVC Group investment in Series A - BociMed
Richen Capital
Richen Capital investment in Series A - BociMed
Official Site Inspections
http://www.abc.bocimed.com
- Host name: 114.80.156.43
- IP address: 114.80.156.43
- Location: Shanghai China
- Latitude: 31.0449
- Longitude: 121.4012
- Timezone: Asia/Shanghai
More informations about "BociMed"
BociMed - Crunchbase Company Profile & Funding
BociMed is a company engaged in drug research and development and clinical research. Through the establishment of a standardized service system, it provides high-quality R&D and …See details»
About Us-Shanghai Bocimed Pharmaceutical Research …
Certified by Pudong New Area R&D Organization. Excellence Award of "Driven by Science and Technology 2020" Key Special Project certified by Pudong New Area R&D Organization. A Caring Enterprise against COVID-19. Top 20 …See details»
Shanghai Bocimed Pharmaceutical Research Co.,LTD
BociMed is a specialized large-scale drug R&D & manufacturing service platform integrating drug synthesis, pharmaceutical and clinical research services. Explore More. Chemical Services, Manufacturing & Control Delivery Technology …See details»
关于我们-上海博志研新药物研究有限公司 - BociMed
博志研新是一家多样化药物递送技术平台型企业，通过十余年的沉淀，拥有高素质的国际化研发团队 400 多人， 600 多套 sop/smp 及流程文件， 200+ 药品项目的研发经验及丰富的国际化注 …See details»
BociMed
Bring Better Medicine to the World. 为世界带来更好的药品See details»
BociMed Company Profile 2024: Valuation, Funding & Investors
BociMed General Information Description. Developer of a drug delivery technology platform created to carry out a series of research and development services such as drug discovery, …See details»
Clinical Research Services-Shanghai Bocimed Pharmaceutical …
Chengdu Runze Pharmaceutical Technology Development Co., Ltd. is the clinical service center of BociMed, which is a professional Clinical Research Organization（CRO）, providing clinical …See details»
Bocimed - Products, Competitors, Financials, Employees, …
BociMed Closed CNY 100 Mn in A New Financing Round. Feb 16, 2023. Healthcare Author: Lingxi Peng Updated 13 mins ago (GMT+8) After this financing, BociMed will implement …See details»
BociMed - Funding, Financials, Valuation & Investors - Crunchbase
BociMed is a company engaged in drug research and development and clinical research. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. Resources. ... How …See details»
BociMed - Crunchbase
BociMed is a company engaged in drug research and development and clinical research.See details»
BCM331 - Drug Targets, Indications, Patents - Synapse
BCM331, Initially developed by Shanghai Bocimed Pharmaceutical Co., Ltd., Now, its global highest R&D status is Preclinical, Active Org.: Shanghai Bocimed Pharmaceutical Co., Ltd.. ...See details»
BCM875 - Drug Targets, Indications, Patents - Synapse - Patsnap
BCM875, Initially developed by Shanghai Bocimed Pharmaceutical Co., Ltd., Now, its global highest R&D status is IND Application, Active Org.: Shanghai Bocimed Pharmaceutical Co., …See details»
Series C - BociMed - 2021-05-01 - Crunchbase Funding Round …
May 1, 2021 Organization Name . BociMed . Announced Date May 1, 2021; Funding Type Series C; Funding Stage Late Stage Venture; Investors. Edit Investors Section. Number of …See details»
A mystery illness has killed dozens of people in Congo. UN
17 hours ago KINSHASA, Congo -- The World Health Organization said Friday it was deploying experts to investigate a mystery flu-like illness that has killed dozens of people in southwest …See details»
BCM476 - Drug Targets, Indications, Patents - Synapse - Patsnap
Nov 21, 2024 BCM476, Initially developed by Shanghai Bocimed Pharmaceutical Co., Ltd., Now, its global highest R&D status is IND Approval, Therapeutic Areas: Cardiovascular ...See details»
A mystery illness has killed dozens in Congo. UN experts are now ...
10 hours ago The World Health Organization said Friday it was deploying experts to investigate a mystery flu-like illness that has killed dozens of people in southwest Congo in recent weeks.See details»
ABC National > Find Chapters
Talk to an ABC strategic partner to learn how they can help your company win and deliver work. Associated Builders and Contractors is a national construction industry trade association …See details»
Prescribed Organization List - BC Accessibility HUB
Prescribed Organization List. Find organizations by sector (deadline for compliance is Sept. 1, 2023, unless it is denoted as 2024 which makes the deadline Sept. 1, 2024 – pleas note that …See details»
BCM-332 - Drug Targets, Indications, Patents - Synapse - Patsnap
BCM-332, Initially developed by Shanghai Bocimed Pharmaceutical Co., Ltd., Now, its global highest R&D status is Phase 1, Therapeutic Areas: Nervous System Diseases ...See details»
BCM899 - Drug Targets, Indications, Patents - Synapse
BCM899, Initially developed by Shanghai Bocimed Pharmaceutical Co., Ltd., Now, its global highest R&D status is IND Approval, Therapeutic Areas: Cardiovascular ...See details»